Click here to get full coverage on Morning Market Movers: ZYME, WSHP, TAIT, RPTX See Big Swings - RTTNews

Morning Market Movers: ZYME, WSHP, TAIT, RPTX See Big Swings  RTTNews

Morning Market Movers: ZYME, WSHP, TAIT, RPTX See Big Swings - RTTNews

Click here to get full coverage on RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders - Business Wire

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders  Business Wire

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders - Business Wire

Click here to get full coverage on Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - Benzinga

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value  Benzinga

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - Benzinga

Click here to get full coverage on Repare (NASDAQ: RPTX) enters definitive deal to be acquired; holders to get $1.82 plus one CVR - Stock Titan

Repare (NASDAQ: RPTX) enters definitive deal to be acquired; holders to get $1.82 plus one CVR  Stock Titan

Repare (NASDAQ: RPTX) enters definitive deal to be acquired; holders to get $1.82 plus one CVR - Stock Titan

Click here to get full coverage on Will RPTX stock deliver better than expected guidance - Entry Point & Low Drawdown Trading Strategies - newser.com

Will RPTX stock deliver better than expected guidance - Entry Point & Low Drawdown Trading Strategies  newser.com

Will RPTX stock deliver better than expected guidance - Entry Point & Low Drawdown Trading Strategies - newser.com

Click here to get full coverage on Repare Therapeutics (RPTX) to Be Acquired by XenoTherapeutics - GuruFocus

Repare Therapeutics (RPTX) to Be Acquired by XenoTherapeutics  GuruFocus

Repare Therapeutics (RPTX) to Be Acquired by XenoTherapeutics - GuruFocus

Click here to get full coverage on Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3 - Yahoo News Malaysia

Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3  Yahoo News Malaysia

Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3 - Yahoo News Malaysia

Click here to get full coverage on Repare Therapeutics (NASDAQ:RPTX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Repare Therapeutics (NASDAQ:RPTX) Upgraded by Wall Street Zen to Hold Rating  MarketBeat

Repare Therapeutics (NASDAQ:RPTX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Click here to get full coverage on Repare Therapeutics Inc. (RPTX) Stock: Falls as XenoTherapeutics Deal Offers Cash and Future Royalties - parameter.io

Repare Therapeutics Inc. (RPTX) Stock: Falls as XenoTherapeutics Deal Offers Cash and Future Royalties  parameter.io

Repare Therapeutics Inc. (RPTX) Stock: Falls as XenoTherapeutics Deal Offers Cash and Future Royalties - parameter.io

Click here to get full coverage on Repare Therapeutics Announces Acquisition by XenoTherapeutics - TipRanks

Repare Therapeutics Announces Acquisition by XenoTherapeutics  TipRanks

Repare Therapeutics Announces Acquisition by XenoTherapeutics - TipRanks

Click here to get full coverage on Will RPTX stock benefit from commodity prices - Earnings Growth Summary & Reliable Price Breakout Signals - newser.com

Will RPTX stock benefit from commodity prices - Earnings Growth Summary & Reliable Price Breakout Signals  newser.com

Will RPTX stock benefit from commodity prices - Earnings Growth Summary & Reliable Price Breakout Signals - newser.com

Click here to get full coverage on Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely - Yahoo Finance

Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely  Yahoo Finance

Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely - Yahoo Finance

Click here to get full coverage on XenoTherapeutics to Acquire Repare Therapeutics (RPTX) in New De - GuruFocus

XenoTherapeutics to Acquire Repare Therapeutics (RPTX) in New De  GuruFocus

XenoTherapeutics to Acquire Repare Therapeutics (RPTX) in New De - GuruFocus

Click here to get full coverage on Real time social sentiment graph for RPTX - Market Volume Report & Capital Efficient Trade Techniques - newser.com

Real time social sentiment graph for RPTX - Market Volume Report & Capital Efficient Trade Techniques  newser.com

Real time social sentiment graph for RPTX - Market Volume Report & Capital Efficient Trade Techniques - newser.com

Click here to get full coverage on RPTX Reports Q3 Revenue Increase from Collaboration Agreements - GuruFocus

RPTX Reports Q3 Revenue Increase from Collaboration Agreements  GuruFocus

RPTX Reports Q3 Revenue Increase from Collaboration Agreements - GuruFocus

Click here to get full coverage on Is this a good reentry point in RPTX - Trend Reversal & Reliable Entry Point Trade Alerts - newser.com

Is this a good reentry point in RPTX - Trend Reversal & Reliable Entry Point Trade Alerts  newser.com

Is this a good reentry point in RPTX - Trend Reversal & Reliable Entry Point Trade Alerts - newser.com

Click here to get full coverage on Real time social sentiment graph for RPTX - Earnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com

Real time social sentiment graph for RPTX - Earnings Risk Summary & Weekly Watchlist for Consistent Profits  newser.com

Real time social sentiment graph for RPTX - Earnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com

Click here to get full coverage on Will RPTX stock benefit from commodity prices - July 2025 Outlook & Reliable Intraday Trade Plans - newser.com

Will RPTX stock benefit from commodity prices - July 2025 Outlook & Reliable Intraday Trade Plans  newser.com

Will RPTX stock benefit from commodity prices - July 2025 Outlook & Reliable Intraday Trade Plans - newser.com

Click here to get full coverage on Will RPTX stock benefit from commodity prices - Stop Loss & Long-Term Growth Stock Strategies - newser.com

Will RPTX stock benefit from commodity prices - Stop Loss & Long-Term Growth Stock Strategies  newser.com

Will RPTX stock benefit from commodity prices - Stop Loss & Long-Term Growth Stock Strategies - newser.com

Click here to get full coverage on Is this a good reentry point in RPTX - Quarterly Market Summary & Risk Managed Investment Strategies - newser.com

Is this a good reentry point in RPTX - Quarterly Market Summary & Risk Managed Investment Strategies  newser.com

Is this a good reentry point in RPTX - Quarterly Market Summary & Risk Managed Investment Strategies - newser.com

Click here to get full coverage on RPTX: Acquisition by XenoTherapeutics announced; $11.6M revenue and $3.3M net income for the quarter - TradingView

RPTX: Acquisition by XenoTherapeutics announced; $11.6M revenue and $3.3M net income for the quarter  TradingView

RPTX: Acquisition by XenoTherapeutics announced; $11.6M revenue and $3.3M net income for the quarter - TradingView

Click here to get full coverage on Why RPTX stock could rally in 2025 - Earnings Summary Report & Proven Capital Preservation Methods - Fundação Cultural do Pará

Why RPTX stock could rally in 2025 - Earnings Summary Report & Proven Capital Preservation Methods  Fundação Cultural do Pará

Why RPTX stock could rally in 2025 - Earnings Summary Report & Proven Capital Preservation Methods - Fundação Cultural do Pará

Click here to get full coverage on Repare Therapeutics stock rating downgraded to Hold by TD Cowen after acquisition news - Investing.com

Repare Therapeutics stock rating downgraded to Hold by TD Cowen after acquisition news  Investing.com

Repare Therapeutics stock rating downgraded to Hold by TD Cowen after acquisition news - Investing.com

Click here to get full coverage on Is RPTX stock reversal real or fake - 2025 Growth vs Value & Reliable Breakout Forecasts - newser.com

Is RPTX stock reversal real or fake - 2025 Growth vs Value & Reliable Breakout Forecasts  newser.com

Is RPTX stock reversal real or fake - 2025 Growth vs Value & Reliable Breakout Forecasts - newser.com

Click here to get full coverage on Repare Therapeutics Inc. SEC 10-Q Report - TradingView

Repare Therapeutics Inc. SEC 10-Q Report  TradingView

Repare Therapeutics Inc. SEC 10-Q Report - TradingView

Click here to get full coverage on RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders - Bluefield Daily Telegraph

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders  Bluefield Daily Telegraph

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders - Bluefield Daily Telegraph

Click here to get full coverage on HC Wainwright & Co. Maintains Repare Therapeutics (RPTX) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains Repare Therapeutics (RPTX) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains Repare Therapeutics (RPTX) Buy Recommendation - Nasdaq

Click here to get full coverage on RPTX - Repare Therapeutics Inc. Latest Stock News & Market Updates - Stock Titan

RPTX - Repare Therapeutics Inc. Latest Stock News & Market Updates  Stock Titan

RPTX - Repare Therapeutics Inc. Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Real time social sentiment graph for RPTX - July 2025 Sector Moves & Growth Focused Entry Reports - newser.com

Real time social sentiment graph for RPTX - July 2025 Sector Moves & Growth Focused Entry Reports  newser.com

Real time social sentiment graph for RPTX - July 2025 Sector Moves & Growth Focused Entry Reports - newser.com

Click here to get full coverage on Will RPTX stock benefit from commodity prices - Forecast Cut & AI Based Buy and Sell Signals - newser.com

Will RPTX stock benefit from commodity prices - Forecast Cut & AI Based Buy and Sell Signals  newser.com

Will RPTX stock benefit from commodity prices - Forecast Cut & AI Based Buy and Sell Signals - newser.com

Click here to get full coverage on Is this a good reentry point in RPTX - Quarterly Performance Summary & Reliable Price Breakout Signals - newser.com

Is this a good reentry point in RPTX - Quarterly Performance Summary & Reliable Price Breakout Signals  newser.com

Is this a good reentry point in RPTX - Quarterly Performance Summary & Reliable Price Breakout Signals - newser.com

Click here to get full coverage on New Analyst Forecast: $RPTX Given $3.0 Price Target | RPTX Stock News - Quiver Quantitative

New Analyst Forecast: $RPTX Given $3.0 Price Target | RPTX Stock News  Quiver Quantitative

New Analyst Forecast: $RPTX Given $3.0 Price Target | RPTX Stock News - Quiver Quantitative

Click here to get full coverage on Will RPTX stock deliver better than expected guidance - Weekly Trend Summary & Stock Portfolio Risk Management - newser.com

Will RPTX stock deliver better than expected guidance - Weekly Trend Summary & Stock Portfolio Risk Management  newser.com

Will RPTX stock deliver better than expected guidance - Weekly Trend Summary & Stock Portfolio Risk Management - newser.com

Click here to get full coverage on Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates  Yahoo Finance

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Real time social sentiment graph for RPTX - 2025 Major Catalysts & Safe Capital Growth Trade Ideas - newser.com

Real time social sentiment graph for RPTX - 2025 Major Catalysts & Safe Capital Growth Trade Ideas  newser.com

Real time social sentiment graph for RPTX - 2025 Major Catalysts & Safe Capital Growth Trade Ideas - newser.com

Click here to get full coverage on Repare Therapeutics (RPTX) Projected to Post Earnings on Thursday - MarketBeat

Repare Therapeutics (RPTX) Projected to Post Earnings on Thursday  MarketBeat

Repare Therapeutics (RPTX) Projected to Post Earnings on Thursday - MarketBeat

Click here to get full coverage on Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders - Your Wyoming Link

Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders  Your Wyoming Link

Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders - Your Wyoming Link

Click here to get full coverage on HC Wainwright Has Lowered Expectations for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat

HC Wainwright Has Lowered Expectations for Repare Therapeutics (NASDAQ:RPTX) Stock Price  MarketBeat

HC Wainwright Has Lowered Expectations for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat

Click here to get full coverage on Repare Therapeutics Secures Massive $267M Cancer Drug Deal, Shifts Focus to Two Promising Phase 1 Trials - Stock Titan

Repare Therapeutics Secures Massive $267M Cancer Drug Deal, Shifts Focus to Two Promising Phase 1 Trials  Stock Titan

Repare Therapeutics Secures Massive $267M Cancer Drug Deal, Shifts Focus to Two Promising Phase 1 Trials - Stock Titan

Click here to get full coverage on Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move - TipRanks

Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move  TipRanks

Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move - TipRanks

Click here to get full coverage on RPTX: Analyst Lowers Target Price While Maintaining Buy Rating | - GuruFocus

RPTX: Analyst Lowers Target Price While Maintaining Buy Rating |  GuruFocus

RPTX: Analyst Lowers Target Price While Maintaining Buy Rating | - GuruFocus

Click here to get full coverage on Repare Therapeutics' (RPTX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Repare Therapeutics' (RPTX) "Sell (D-)" Rating Reiterated at Weiss Ratings  MarketBeat

Repare Therapeutics' (RPTX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Click here to get full coverage on Q1 Earnings Forecast for RPTX Issued By HC Wainwright - MarketBeat

Q1 Earnings Forecast for RPTX Issued By HC Wainwright  MarketBeat

Q1 Earnings Forecast for RPTX Issued By HC Wainwright - MarketBeat

Click here to get full coverage on Will RPTX stock outperform Dow Jones index - Weekly Profit Report & AI Forecast Swing Trade Picks - newser.com

Will RPTX stock outperform Dow Jones index - Weekly Profit Report & AI Forecast Swing Trade Picks  newser.com

Will RPTX stock outperform Dow Jones index - Weekly Profit Report & AI Forecast Swing Trade Picks - newser.com

Click here to get full coverage on Can RPTX stock reach $100 price target - Portfolio Update Report & Expert Curated Trade Ideas - newser.com

Can RPTX stock reach $100 price target - Portfolio Update Report & Expert Curated Trade Ideas  newser.com

Can RPTX stock reach $100 price target - Portfolio Update Report & Expert Curated Trade Ideas - newser.com

Click here to get full coverage on Why RPTX stock could outperform in 2025 - Swing Trade & AI Driven Stock Price Forecasts - newser.com

Why RPTX stock could outperform in 2025 - Swing Trade & AI Driven Stock Price Forecasts  newser.com

Why RPTX stock could outperform in 2025 - Swing Trade & AI Driven Stock Price Forecasts - newser.com

Click here to get full coverage on Repare Therapeutics shares update on RP-1664 Phase 1 trial abstract release - Investing.com

Repare Therapeutics shares update on RP-1664 Phase 1 trial abstract release  Investing.com

Repare Therapeutics shares update on RP-1664 Phase 1 trial abstract release - Investing.com

Click here to get full coverage on Why RPTX stock could rally in 2025 - 2025 Volatility Report & Precise Swing Trade Entry Alerts - newser.com

Why RPTX stock could rally in 2025 - 2025 Volatility Report & Precise Swing Trade Entry Alerts  newser.com

Why RPTX stock could rally in 2025 - 2025 Volatility Report & Precise Swing Trade Entry Alerts - newser.com

Click here to get full coverage on Repare Therapeutics Announces Phase 1 LIONS Trial Abstract Release - TradingView

Repare Therapeutics Announces Phase 1 LIONS Trial Abstract Release  TradingView

Repare Therapeutics Announces Phase 1 LIONS Trial Abstract Release - TradingView

Click here to get full coverage on Repare Therapeutics Unveils Phase 1 LIONS Trial Data - TipRanks

Repare Therapeutics Unveils Phase 1 LIONS Trial Data  TipRanks

Repare Therapeutics Unveils Phase 1 LIONS Trial Data - TipRanks

Click here to get full coverage on Repare Therapeutics stock price target cut as H.C. Wainwright questions drug candidate - Investing.com

Repare Therapeutics stock price target cut as H.C. Wainwright questions drug candidate  Investing.com

Repare Therapeutics stock price target cut as H.C. Wainwright questions drug candidate - Investing.com

Click here to get full coverage on Repare Therapeutics stock surges after $10M licensing deal with Debiopharm - Investing.com

Repare Therapeutics stock surges after $10M licensing deal with Debiopharm  Investing.com

Repare Therapeutics stock surges after $10M licensing deal with Debiopharm - Investing.com

Click here to get full coverage on XenoTherapeutics to acquire Repare Therapeutics for $1.82 per share - Investing.com India

XenoTherapeutics to acquire Repare Therapeutics for $1.82 per share  Investing.com India

XenoTherapeutics to acquire Repare Therapeutics for $1.82 per share - Investing.com India

Click here to get full coverage on Cathie Wood’s ARK Buys PACB Stock, Sells ANSS and RPTX - Investing.com

Cathie Wood’s ARK Buys PACB Stock, Sells ANSS and RPTX  Investing.com

Cathie Wood’s ARK Buys PACB Stock, Sells ANSS and RPTX - Investing.com

Click here to get full coverage on Repare Therapeutics licenses PKMYT1 inhibitor to Debiopharm for $10 million - Investing.com

Repare Therapeutics licenses PKMYT1 inhibitor to Debiopharm for $10 million  Investing.com

Repare Therapeutics licenses PKMYT1 inhibitor to Debiopharm for $10 million - Investing.com

Click here to get full coverage on Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results  Yahoo Finance

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance

Click here to get full coverage on Repare Therapeutics Appoints Steve Forte CEO - citybiz

Repare Therapeutics Appoints Steve Forte CEO  citybiz

Repare Therapeutics Appoints Steve Forte CEO - citybiz

Click here to get full coverage on Repare Therapeutics Shares Drop 38% Following Phase 1 Trial Results - Yahoo Finance

Repare Therapeutics Shares Drop 38% Following Phase 1 Trial Results  Yahoo Finance

Repare Therapeutics Shares Drop 38% Following Phase 1 Trial Results - Yahoo Finance

Click here to get full coverage on Repare Therapeutics to cut 75% of workforce in major restructuring - The Pharma Letter

Repare Therapeutics to cut 75% of workforce in major restructuring  The Pharma Letter

Repare Therapeutics to cut 75% of workforce in major restructuring - The Pharma Letter

Click here to get full coverage on Cathie Wood Snags Robinhood Stock (HOOD) and GitLab (GTLB) as Markets Slide - The Globe and Mail

Cathie Wood Snags Robinhood Stock (HOOD) and GitLab (GTLB) as Markets Slide  The Globe and Mail

Cathie Wood Snags Robinhood Stock (HOOD) and GitLab (GTLB) as Markets Slide - The Globe and Mail

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics - The Globe and Mail

Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics  The Globe and Mail

Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics - The Globe and Mail

Click here to get full coverage on Cambridge-Montreal biotech lets go 75% of employees - The Business Journals

Cambridge-Montreal biotech lets go 75% of employees  The Business Journals

Cambridge-Montreal biotech lets go 75% of employees - The Business Journals

Click here to get full coverage on Repare (RPTX) Up 20% on Deal With Roche for Solid Tumor Drug - Nasdaq

Repare (RPTX) Up 20% on Deal With Roche for Solid Tumor Drug  Nasdaq

Repare (RPTX) Up 20% on Deal With Roche for Solid Tumor Drug - Nasdaq

Click here to get full coverage on RPTX Stock Price and Chart — NASDAQ:RPTX - TradingView

RPTX Stock Price and Chart — NASDAQ:RPTX  TradingView

RPTX Stock Price and Chart — NASDAQ:RPTX - TradingView

Click here to get full coverage on Repare Therapeutics (RPTX.Q) stock is ripping! Here’s why! - Equity.Guru

Repare Therapeutics (RPTX.Q) stock is ripping! Here’s why!  Equity.Guru

Repare Therapeutics (RPTX.Q) stock is ripping! Here’s why! - Equity.Guru

Click here to get full coverage on Repare Therapeutics (RPTX) Stock Price, Quote, News & History - Benzinga

Repare Therapeutics (RPTX) Stock Price, Quote, News & History  Benzinga

RPTX

Price Chart

Key Statistics

Technicals

About RPTX

Latest News

Morning Market Movers: ZYME, WSHP, TAIT, RPTX See Big Swings - RTTNews

RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders - Business Wire

Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - Benzinga

Advanced Charts

Top Gainers

Top Losers